title: UK parses merits of value-based drug pricing.
authors.forename: Nuala
authors.initials: N
authors.lastname: Moran
mesh_terms: D003363:Cost Control; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000331:legislation & jurisprudence; D017850:Economics, Pharmaceutical; D006113:United Kingdom